Search and analyze individual stocks with comprehensive metrics
Strides Pharma Science Limited
Fundamental Score
Strides Pharma Science Limited Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of STAR across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (150.67%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Attractive Valuation (P/E: 20.84 vs Industry: 33.97)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (41.26%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Excellent EPS Growth (122.76% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (124.04% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Cash Generation (₹1000.52 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 41.32%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Risk Factors
2 factors identified
Low Promoter Commitment (28.30%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
High Share Pledging Risk (50.10%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns or margin calls.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Strides Pharma Science Limited
About STAR
Company Details
Market Information
Performance
STAR Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of STAR?
STAR is currently trading at ₹830.05 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of STAR shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of STAR and what does it mean?
STAR has a P/E ratio of 20.84x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹21 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is STAR performing according to Bull Run's analysis?
STAR has a Bull Run fundamental score of 58.1/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 150.67%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does STAR belong to?
STAR operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Strides Pharma Science Limited. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for STAR?
STAR has an ROE of 150.67%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Strides Pharma Science Limited generates profits from shareholders' equity. An ROE of 151% means the company generates ₹151 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is STAR's debt-to-equity ratio and what does it indicate?
STAR has a debt-to-equity ratio of 0.74, which indicates moderate leverage that should be monitored. This means the company has ₹74 of debt for every ₹100 of equity. Higher leverage can amplify returns during good times but increases bankruptcy risk during downturns.
What is STAR's dividend yield and is it a good dividend stock?
STAR offers a dividend yield of 0.47%, which means you receive ₹0.47 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has STAR grown over the past 5 years?
STAR has achieved 5-year growth rates of: Sales Growth 10.65%, Profit Growth 124.04%, and EPS Growth 122.76%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in STAR and why does it matter?
Promoters hold 28.30% of STAR shares, with 50.10% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. High pledging is concerning as it can create selling pressure during market stress. Recent change in promoter holding: 0.00%.
How does STAR compare with its industry peers?
STAR trades at P/E 20.84x vs industry average 33.97x, with ROE of 150.67% and ROCE of 14.68%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether STAR is outperforming its competitive set in profitability, growth, and valuation metrics.
What is STAR's market capitalization and what category does it fall into?
STAR has a market capitalization of ₹7809 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for STAR?
Key ratios for STAR: ROE 150.67% (Excellent), ROCE 14.68%, P/E 20.84x, Debt-to-Equity 0.74, Interest Coverage 3.10x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is STAR stock and what is its beta?
STAR has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for STAR?
STAR has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹830.05, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in STAR?
Key risks for STAR include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.74), and operational challenges. The stock has a Fundamental Score of 58.1/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is STAR's operating profit margin and how has it trended?
STAR has a 5-year average Operating Profit Margin (OPM) of 10.16%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is STAR's quarterly performance in terms of sales and profit growth?
STAR's recent quarterly performance shows YoY Sales Growth of 6.20% and YoY Profit Growth of 41.26%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in STAR?
STAR has FII holding of 28.02% and DII holding of 13.30%, totaling 41.32% institutional ownership. High institutional holding indicates professional validation of business quality and growth prospects. Significant FII holding suggests global investor confidence and potential for index inclusion. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.